AEP
58
2
MNST
49
-3
NEM
48
2
BWA
45
-4
NVDA
52
-3
DE
53
8
VZ
47
2
BRK.B
42
-3
GOOG
67
2
PEP
47
-3
AVY
53
-9
DHR
56
-4
O
31
3
CMA
62
-2
HIG
68
4
SWKS
38
-2
NTRS
49
-5
SBUX
41
-3
HON
47
-12
TAP
45
-6
AEP
58
2
MNST
49
-3
NEM
48
2
BWA
45
-4
NVDA
52
-3
DE
53
8
VZ
47
2
BRK.B
42
-3
GOOG
67
2
PEP
47
-3
AVY
53
-9
DHR
56
-4
O
31
3
CMA
62
-2
HIG
68
4
SWKS
38
-2
NTRS
49
-5
SBUX
41
-3
HON
47
-12
TAP
45
-6
Financhill
Back

Imerys Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
42

IMYSF
Imerys

Last Price:
31.95
Seasonality Move:
8.15%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
42
Imerys (IMYSF) is a Sell

Is Imerys a Buy, Sell or Hold?

  • The current Imerys [IMYSF] share price is $31.95. The Score for IMYSF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • IMYSF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

IMYSF Stock Price Chart

What is Imerys's stock price today?

  • The Imerys share price today is $31.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMYSF is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

IMYSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 31.13 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.06 - 33.54) Sell
Bollinger Bands (100): (30.68 - 32.36) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

IMYSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.52 Sell
20-day SMA: 33.01 Sell
50-day SMA: 32 Sell
200-day SMA: 31.7 Buy
8-day EMA: 32.37 Sell
20-day EMA: 32.59 Sell
50-day EMA: 32.32 Sell
200-day EMA: 34.17 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Imerys Earnings Growth & IMYSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Imerys Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):